Daniel Alkon
Präsident bei NEUROTROPE, INC.
Vermögen: 6 275 $ am 30.04.2024
Aktive Positionen von Daniel Alkon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEUROTROPE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.08.2013 | - |
| Präsident | 19.09.2016 | - | |
| SYNAPTOGENIX, INC. | Direktor/Vorstandsmitglied | 07.12.2020 | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - | |
| Präsident | - | - |
Karriereverlauf von Daniel Alkon
Ehemalige bekannte Positionen von Daniel Alkon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Blanchette Rockefeller Neurosciences Institute
 Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Blanchette Rockefeller Neurosciences Institute provides health care solutions. The company offers to facilitate molecular signaling, which controls the functions that record our conscience experience. The company is headquartered in Morgantown, WV. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 | 23.09.2016 |
| West Virginia University | Corporate Officer/Principal | - | 01.09.2016 |
Adaptive Systems, Inc.
 Adaptive Systems, Inc. Computer Processing HardwareElectronic Technology Adaptive Systems, Inc. manufactures and develops small, high performance modular hardware products for use by the embedded computer industry. It products include 486DX 66MHz, 586-133MHz Processors; System Management; Super I/O, VGA, PCMCIA; and Sound O/S. The company is headquartered in Longmont, CO. | Corporate Officer/Principal | - | - |
| National Institute of Neurological Disorders & Stroke | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Daniel Alkon
| University of Pennsylvania | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| President | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYNAPTOGENIX, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
Blanchette Rockefeller Neurosciences Institute
Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Blanchette Rockefeller Neurosciences Institute provides health care solutions. The company offers to facilitate molecular signaling, which controls the functions that record our conscience experience. The company is headquartered in Morgantown, WV. | Health Technology |
| National Institute of Neurological Disorders & Stroke | Government |
Adaptive Systems, Inc.
Adaptive Systems, Inc. Computer Processing HardwareElectronic Technology Adaptive Systems, Inc. manufactures and develops small, high performance modular hardware products for use by the embedded computer industry. It products include 486DX 66MHz, 586-133MHz Processors; System Management; Super I/O, VGA, PCMCIA; and Sound O/S. The company is headquartered in Longmont, CO. | Electronic Technology |
- Börse
- Insiders
- Daniel Alkon
- Erfahrung
